MAPT and Alzheimer disease: <b>Objective:</b> Alzheimer's disease (AD) is traditionally characterized by amyloid-β and tau pathology; however, accumulating evidence indicates that metabolic and inflammatory dysfunctions are early, central contributors to disease development.